[Adjuvant therapy in breast carcinoma. A specific immunologic preliminary contribution].
Fazio
M
M
Calabrese
F
F
Giacomasso
S
S
Mastromatteo
V
V
Negri
L
L
D000367:Age Factors; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D011379:Prognosis; D013629:Tamoxifen / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D013629:Tamoxifen
La terapia adiuvante nel carcinoma mammario. Preliminare contributo immunologico specifico.